1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantscWIDR Support is sponsored by Washington University in St. Louis. Supports the Center for Women's Infectious Disease Research, which conducts research in infectious diseases affecting women.
Get alerted about grants like this
Save a search for “Washington University in St. Louis” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
2015 Call for Pilot Research Project Applications | Center for Women's Infectious Disease Research 2015 Call for Pilot Research Project Applications Objective: to encourage and support new research and translational studies at Washington University on infectious diseases that affect women’s health. Goal: to attract investigators who are interested in initiating research on infectious disease in women.
Our priority is on new research (not currently funded by internal or external mechanisms) that will lead to a future application with an external funding agency. Proposals that utilize a wide range of research methods and interdisciplinary perspectives are highly encouraged.
Research Area: Infectious diseases in females Examples of area of interest – proposals should initiate new research or the development of tools to study: A pathogen or infectious disease that predominantly affects women or girls A pathogen or infectious disease that may affect females differently than males at any stage of life Differences in the way that male and female immune systems respond to infection Genetic differences in hosts or microbes that predispose females vs males to an infection or sequelae 5:00 pm on June 30, 2015.
Email a single PDF to betty@wustl. edu . Awards will be announced by mid-August 2015 September 1, 2015 – August 31, 2016 Up to $25,000 Direct Costs Interdisciplinary projects with awards up to $75,000 Direct costs will also be considered.
All Washington University faculty and Instructors Senior postdoctoral research associates (letter of support from faculty mentor is required) Projects will be reviewed for scientific merit, creativity & innovation, originality & importance, potential for the project to lead to external funding, and ability to advance the cWIDR’s overall mission.
The proposal must include the following: Cover letter describing briefly how the application meets eligibility requirements and program goals (1 paragraph) Budget & Budget Justification (form page 4 & form page 5 ) Approval by WU OSRS is not required NIH Biographical Sketch (5 page maximum) Formatted Other Support (on a continuation page) Sample OS page Resources (1 page maximum – Describe research facilities and major equipment) Research Plan (Five page maximum – NIH format; Significance, Innovation and Approach) Appendices – Letters of Support, Letter from Mentor (Postdocs only) Formatting: Single-spaced, 11 pt.
Arial font, half inch margins, PI name should be on the top right-hand corner of every page of the application. Regulatory approvals (as applicable) will be required for studies involving human subjects, animals, or the use of radiation. Approvals may be pending at the time of submission, but no award will be issued until all approvals have been received.
Reports and acknowledgements: All awarded grantees will be required to submit a brief annual progress report describing the results of their work, as well as related publications and funding. All publications resulting from the award should acknowledge the cWIDR Pilot Research Grant Program at Washington University.
Technical staff salary support Animals, including housing and care Fees for specialized services (microscopy, pathology, photography, etc.) Expenditures NOT Allowed: Principal Investigator salary support Secretarial/administrative personnel salary support Office equipment and supplies Equipment (unit cost of $5,000 or more) Carry over and No-cost Extensions are not allowed
According to the current listing, eligibility includes: Universities, Research Institutions. Confirm the full requirements in the official notice before applying.
cWIDR Support is funded by Washington University in St. Louis. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
AI for Health Seed Funding Program is a grant from the AI for Health Institute and Washington University in St. Louis supporting innovative, interdisciplinary research that applies artificial intelligence to critical health challenges. Projects must bring together WashU faculty from at least two schools — one from AI and one from health — forming genuine collaborative teams. The program runs annually and requires proposals from full-time faculty co-PIs who are current on reporting from prior university seed grants. Awards are intended to catalyze new interdisciplinary partnerships and generate preliminary data for larger external funding pursuits.
CRE2 Arts & Culture Community Grants is sponsored by Washington University in St. Louis - Center for the Study of Race, Ethnicity & Equity (CRE2). These grants support individuals and organizations in the St. Louis metro area engaged in creative practice that forefronts race and/or ethnicity. The goal is to provide direct support for proposals in the humanities, arts, and design that engage the lived realities of the St. Louis Metro region.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
DARPA and NSF launched a joint program on June 1 to fund university work on AI interpretability, control, and adversarial robustness. Awards run $750K to $3M+ per project, the forum launches this summer, and the universities listed in the AI Forge repository will sit closest to the money. The Request for Information closes June 22.
Read articleOn June 1, 2026, DARPA and the National Science Foundation announced AI Forge — a jointly governed forum that will fund, guide, and manage university-led research on AI interpretability, AI control, and adversarial robustness. The RFI on sam.gov closes June 22. The forum itself will be administered by a new nonprofit launching in summer 2026. The structure is what matters: this is not a one-off solicitation, it is a multi-year venue for university-government-industry research that operates outside the normal merit-review timelines of either agency. What university research teams should be doing in the seventeen-day window between the announcement and the RFI deadline — and what the forum model means for federal AI funding through FY 2028.
Read articleThe May 29 OMB rewrite of 2 CFR Part 200 extends what has been a NASA-specific restriction since 2011 to every federal grant-making agency. Proposed §200.220 prohibits use of federal funds for collaboration with entities in or controlled by a 'covered foreign country' — currently the People's Republic of China, Russia, Iran, North Korea, Cuba, and Venezuela. Proposed §200.202(e) requires senior political appointee written approval before any federal R&D award flows to a foreign entity. Together they reshape university international research operations more comprehensively than any policy change since the 2018 China Initiative. Comment deadline July 13.
Read article